Christopher Prentiss

Insider Reports History

Location
Emeryville, CA
Signature
/s/ Christopher Prentiss
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Prentiss:

Company Role Class Num Shares Value Price $ Report Date Ownership
MANNKIND CORP Chief Financial Officer Common Stock, $0.01 Par Value 343,854 $1,323,837 $3.85 15 Jul 2025 Direct
MANNKIND CORP Chief Financial Officer Performance Restricted Stock Unit 145,000 13 May 2025 Direct
Adamas Pharmaceuticals Inc Chief Financial Officer Common Stock 0 $5.16 24 Nov 2021 Direct
Adamas Pharmaceuticals Inc Chief Financial Officer Stock Option (Right to Buy) 0 24 Nov 2021 Direct

Insider Reports Filed by Christopher Prentiss

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNKD MANNKIND CORP 15 Jul 2025 1 -$44,429 4 Chief Financial Officer 17 Jul 2025, 20:45
MNKD MANNKIND CORP 13 May 2025 2 $0 4 Chief Financial Officer 15 May 2025, 20:34
MNKD MANNKIND CORP 15 May 2024 1 $0 4/A Chief Financial Officer 28 Mar 2025, 20:20
MNKD MANNKIND CORP 22 Apr 2024 0 $0 3 Chief Financial Officer 22 Apr 2024, 19:00
/report/000132814321000092-prentiss-christopher-b-2021-11-24 Adamas Pharmaceuticals Inc 24 Nov 2021 4 $0 4 Chief Financial Officer 24 Nov 2021, 15:10